MPM Asset Management LLC Plans to Sell Common Shares of Werewolf Therapeutics, Inc.

MPM Asset Management LLC has filed a notice to sell 20,597 common shares of Werewolf Therapeutics, Inc. The shares were acquired on May 4, 2021, through a private placement. The sale is planned for October 27, 2025, with Merrill Lynch acting as the broker. The aggregate market value of the shares to be sold is $36,456.69. MPM Asset Management LLC has reported no securities sold in the past three months. The filing indicates that the shares are being sold under Rule 144, which governs the sale of restricted and control securities.